Total deaths due to coronavirus pandemic soared to more than 61,000 in the U.S. while total infections jumped to more than 1,065,000. The market sentiments are low, despite the announcement that Gilead Sciences Inc's antiviral drug remdesivir might become the standard of care for Covid-19.
Initial inputs from the U.S. Futures Index suggest that Wall Street might open broadly lower.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com